| Financial Year |
March 31 2023 |
| Monetary Funds |
21,935,937,403.45 |
| Held-for-trading Financial Assets |
7,069,207,063.08 |
| Notes Receivable |
6,467,301,106.81 |
| Accounts Receivable |
44,641,075,493.29 |
| Advances to Suppliers |
2,304,658,589.41 |
| Other Receivables |
2,162,063,891.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
63,078,647.97 |
| Inventories |
34,198,984,365.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,346,125,573.84 |
| Other Current Assets |
4,734,813,943.64 |
| Total Current Assets |
128,244,609,465.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,541,002,766.68 |
| Long-term Equity Investment |
3,939,376,564.82 |
| Investment Properties |
4,763,841.39 |
| Fixed Assetes |
18,709,379,492.32 |
| Under-construction Projects |
3,588,965,204.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,340,945,974.90 |
| R&D expenses |
1,019,304,532.16 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,860,438.79 |
| Deferred Income Tax Assets |
2,697,964,964.95 |
| Other Non-Current Assets |
641,014,781.85 |
| Sub-Total of Non-Current Assets |
47,013,298,470.57 |
| Total Assets |
175,257,907,936.50 |
| Short-Term Loans |
16,149,084,393.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,213,629,915.32 |
| Accounts Payable |
26,205,088,713.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
389,495,624.46 |
| Taxes Payable |
542,322,422.91 |
| Interest Payable |
-- |
| Dividend Payable |
12,828,200.32 |
| Other payables |
6,073,025,493.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,318,964,169.47 |
| Other Current Liabilities |
5,983,579,864.67 |
| Sub-Total of Current Liabilities |
93,707,133,657.54 |
| Long-term Loans |
17,114,110,704.03 |
| Bonds Payable |
2,739,654,183.75 |
| Long-Term Accounts Payable |
3,769,103,008.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
411,502,124.52 |
| Deferred Income Tax Liabilities |
1,028,631,955.05 |
| Other Non-Current Liabilities |
434,613,393.82 |
| Sub-Total of Non-Current Liabilities |
26,150,408,503.50 |
| Total Liabilities |
119,857,542,161.04 |
| Paid-In Capital(Or Share Stock) |
11,816,166,093.00 |
| Capital Surplus |
16,784,069,068.73 |
| Surplus Reserve |
2,089,951,613.16 |
| LESS:Treasury Stock |
852,188,078.74 |
| Undistributed Profits |
24,092,101,196.80 |
| Minority Stockholder's Interest |
1,458,991,747.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
53,941,374,027.95 |
| Owner's Equity（Stockholder's Equity） |
55,400,365,775.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
175,257,907,936.50 |
